NCT00416247

Brief Summary

This study is intended to investigate neurophysiological mechanisms of hypnosis using transcranial magnetic stimulation (TMS) and assessment of motor cortex excitability in healthy volunteers under hypnosis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at P25-P50 for not_applicable healthy

Timeline
Completed

Started Dec 2006

Longer than P75 for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2006

Completed
25 days until next milestone

First Submitted

Initial submission to the registry

December 26, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 27, 2006

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2007

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2009

Completed
Last Updated

August 5, 2010

Status Verified

December 1, 2006

Enrollment Period

1 year

First QC Date

December 26, 2006

Last Update Submit

August 4, 2010

Conditions

Healthy

Keywords

HypnosisTMSCortical excitability

Outcome Measures

Primary Outcomes (1)

  • Cortical Excitability

    Before and after intervention

Interventions

HypnosisBEHAVIORAL

Hypnosis

Eligibility Criteria

Age20 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy volunteers aged 20 to 45 years.
  • Hypnotisability above 14 as measured by the Tellegan absorption scale.

You may not qualify if:

  • Psychiatric diagnosis in axis I or axis II;
  • Documented history of head injury or seizure disorder;
  • Evidence of a disorder which could affect peripheral and central conduction such as multiple sclerosis, motor neuron disease, carpal tunnel syndrome, cervical spondylosis, diabetic neuropathy.
  • Any other contraindication to TMS as specified in the safety guidelines for rTMS (Wassermann, 1998) such as cardiac pacemakers or metallic deep brain electrodes.
  • Chronic pharmacological treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rambam Medical Center

Haifa, 31096, Israel

Location

MeSH Terms

Interventions

Hypnosis

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Ehud Klein, MD

    Rambam Health Care Campus

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

December 26, 2006

First Posted

December 27, 2006

Study Start

December 1, 2006

Primary Completion

December 1, 2007

Study Completion

June 1, 2009

Last Updated

August 5, 2010

Record last verified: 2006-12

Locations

IL(1)